Statins inhibit tumor progression via an enhancer of zeste homolog 2-mediated epigenetic alteration in colorectal cancer

While statin intake has been proven to reduce the risk of colorectal cancer (CRC), the mechanism of antitumor effects and clinical significance in survival benefits remain unclear. Statin-induced antiproliferative effects and its underlying mechanism were examined using six CRC cell lines. Statins e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa, S, Hayashi, H, Kinoshita, K, Abe, M, Kuroki, H, Tokunaga, R, Tomiyasu, S, Tanaka, H, Sugita, H, Arita, T, Yagi, Y, Watanabe, M, Hirota, M, Baba, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Cancer Cell Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233976/
https://www.ncbi.nlm.nih.gov/pubmed/24346863
http://dx.doi.org/10.1002/ijc.28672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233976/
https://www.ncbi.nlm.nih.gov/pubmed/24346863
http://dx.doi.org/10.1002/ijc.28672

Ejemplares similares